Drug intelligence / Profile preview

MegaRed

Development stage
Phase 1
Lead developer
Schiff Vitamins
Modality
Small Molecules
Administration
Oral
01

Overview

MegaRed is a brand of over-the-counter dietary supplements primarily composed of omega-3 fatty acids derived from krill oil and fish oil. Marketed by Schiff (a subsidiary of Reckitt Benckiser), the product line includes various formulations such as MegaRed Omega-3 Krill Oil and MegaRed Advanced 4-in-1. The active ingredients, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are often delivered in phospholipid form when sourced from krill, which is marketed as providing superior absorption compared to traditional fish oil. MegaRed is used to support cardiovascular health by helping to maintain healthy triglyceride levels and is also promoted for joint, brain, and eye health. As a dietary supplement, it is not regulated as a pharmaceutical drug and is not intended to diagnose, treat, cure, or prevent any disease.

Brand names
MegaRedMegaRed Omega-3 Krill OilMegaRed Advanced 6X AbsorptionMegaRed Advanced 4-in-1
Other names
Krill oilOmega-3 krill oilOmega3 krill oilOmega 3 krill oil
02

Targets

FFAR4 (Free fatty acid receptor 4)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on MegaRed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MegaRed.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call